Free Republic
Browse · Search
News/Activism
Topics · Post Article

Skip to comments.

Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: A Danish cohort study (Ineffective against Omicron after a few months)
Medrvix ^ | December 22, 2021 | View ORCID ProfileChristian Holm Hansen, Astrid Blicher Schelde, Ida Rask Moustsen-Helm, Hanne-Dort

Posted on 12/26/2021 8:11:41 AM PST by DoodleBob

In this brief communication we are showing original research results with early estimates from Danish nationwide databases of vaccine effectiveness (VE) against the novel SARS-CoV-2 Omicron variant (B.1.1.529) up to five months after a primary vaccination series with the BNT162b2 or mRNA-1273 vaccines.

Our study provides evidence of protection against infection with the Omicron variant after completion of a primary vaccination series with the BNT162b2 or mRNA-1273 vaccines; in particular, we found a VE against the Omicron variant of 55.2% (95% confidence interval (CI): 23.5 to 73.7%) and 36.7% (95% CI: 69.9 to 76.4%) for the BNT162b2 and mRNA-1273 vaccines, respectively, in the first month after primary vaccination. However, the VE is significantly lower than that against Delta infection and declines rapidly over just a few months. The VE is re-established upon revaccination with the BNT162b2 vaccine (54.6%, 95% CI: 30.4 to 70.4%).

...

By December 12, 2021, there were 5,767 identified Omicron cases in Denmark with a median age of 28 years (93% <60 years). Among those who had most recently completed primary vaccination, VE against Omicron was 55.2% (95% confidence interval: 23.5 to 73.7%) and 36.7% (−69.9 to 76.4%) for the BNT162b2 and mRNA-1273 vaccines, respectively, but with evidence of rapid waning over the course of five months. By comparison, VE against Delta was significantly higher and better preserved over the same period


(Excerpt) Read more at medrxiv.org ...


TOPICS: Culture/Society; News/Current Events
KEYWORDS: omicron; vaccines; ve
VE = the percentage reduction in infection rate provided by a "vaccine" vs the control/unvaxxed group.

In short, the Pfizer and Moderna shots had favorable VEs for Delta though they decayed over time. In contrast, the VEs against Omicron were a low 55% and 37% respectively at 1-30 days after the second shot, and declined such that the vaccinated group had a HIGHER Omicron infection rate vs the control/unvaxxed group at 90+ days after the second shots.

The study suggests a) boosters may be needed to defeat Omicron, and/or b) you're better off without a booster or a shot, and/or, c) boosters forever.

1 posted on 12/26/2021 8:11:41 AM PST by DoodleBob
[ Post Reply | Private Reply | View Replies]

To: DoodleBob

RE: Ineffective against Omicron after a few months

Well, I guess they will have to develop a booster for Omicron, and if another variant arises, another booster, ad infinitum.

This is where the CDC is headed anyway.

You will never be considered fully vaccinated and mandates are to be expected indefinitely.


2 posted on 12/26/2021 8:21:26 AM PST by SeekAndFind
[ Post Reply | Private Reply | To 1 | View Replies]

To: SeekAndFind
Well, I guess they will have to develop a booster for Omicron, and if another variant arises, another booster, ad infinitum.

Bingo.

3 posted on 12/26/2021 8:22:53 AM PST by DoodleBob (Gravity's waiting period is about 9.8 m/s^2)
[ Post Reply | Private Reply | To 2 | View Replies]

To: DoodleBob

The cdc has a statement o. Their website stating that there is no test to detect any variant of covid. If this is true, then how do these studies determine who has variants and how prevalent they are?


4 posted on 12/26/2021 8:23:40 AM PST by Bob434
[ Post Reply | Private Reply | To 1 | View Replies]

To: DoodleBob

bkmk


5 posted on 12/26/2021 8:24:12 AM PST by sauropod (Resident Bidet. A confused old man at the wrong bus stop.)
[ Post Reply | Private Reply | To 1 | View Replies]

To: DoodleBob

Also, omicron is said to be bery bery mild, so why are they needing vaccines that don’t work agaisnt it? To increase its resistance to vaccines?


6 posted on 12/26/2021 8:24:56 AM PST by Bob434
[ Post Reply | Private Reply | To 1 | View Replies]

To: Bob434

Either they estimated the Omicron/ Delta mix or the Danes are smarter. Or they made it up.


7 posted on 12/26/2021 8:31:05 AM PST by DoodleBob (Gravity's waiting period is about 9.8 m/s^2)
[ Post Reply | Private Reply | To 4 | View Replies]

To: DoodleBob

I’ll stick with my 85% effective Zelenko/FLCC early treatment protocol. Wife tested positive at the nursing home she works at. Got a required follow-up test two days later which we did on our way to get her Monoclonal Antibody Infusion. Both taking all the vitamins and I’m on day three of the five day course of IVM. Both doing pretty durn good. I’m feeling well enough to go out and process some firewood in a little while. We have no idea if it’s Delta or Omicron.


8 posted on 12/26/2021 8:34:10 AM PST by Pollard (PureBlood -- youtube.com/watch?v=VXm0fkDituE)
[ Post Reply | Private Reply | To 1 | View Replies]

To: Bob434

As I understand it, variants have to be identified by genetic sequencing beyond a regular test (which is expensive and takes time), and a certain percentage of tests are automatically evaluated via sequencing.


9 posted on 12/26/2021 8:39:16 AM PST by M1903A1 ("We shed all that is good and virtuous for that which is shoddy and sleazy...and call it progress" )
[ Post Reply | Private Reply | To 4 | View Replies]

To: DoodleBob

The booster should win this year’s TIME Magazine thingy of the year.


10 posted on 12/26/2021 9:05:12 AM PST by bgill (Which came first, the vax or the virus?)
[ Post Reply | Private Reply | To 1 | View Replies]

To: SeekAndFind
Well, I guess they will have to develop a booster for Omicron, and if another variant arises, another booster, ad infinitum.

Isn't this essentially the model used by Big Pharma using traditional vaccine methodology for the flu every year?

11 posted on 12/26/2021 9:20:44 AM PST by MacNaughton
[ Post Reply | Private Reply | To 2 | View Replies]

To: SeekAndFind
You will never be considered fully vaccinated and mandates are to be expected indefinitely.

Our neighbor told us 2 days ago that their 20-year old daughter, a college sophomore, had recently went to the ER for an unrelated condition. They tested her for COVID while she was there and it came back positive. This kid came down with COVID back in JAN 2021, was sent home, and quarantined there. Since then she has had the 2 clot shots and the booster. Her only current symptom is a headache. So she had acquired immunity and "vaccine"/ gene therapy immunity, at least for COVID alpha-delta.

12 posted on 12/26/2021 9:27:52 AM PST by MacNaughton
[ Post Reply | Private Reply | To 2 | View Replies]

To: MacNaughton

You mentioned that she recovered from Covid in January 2021.

How do we know that her acquired immunity now is not from that past infection and recovery?


13 posted on 12/26/2021 9:32:08 AM PST by SeekAndFind
[ Post Reply | Private Reply | To 12 | View Replies]

To: M1903A1

I dunno but the cdc has the statement on their site, I’ll look it,up


14 posted on 12/26/2021 9:36:25 AM PST by Bob434
[ Post Reply | Private Reply | To 9 | View Replies]

To: M1903A1

https://www.cdc.gov/csels/dls/locs/2021/12-03-2021-lab-alert-CDC_Update_SARS-CoV-2_Omicron_Variant.html

What Laboratories Should Know:

There are no authorized, cleared, or approved diagnostic tests to specifically detect SARS-CoV-2 variants (Omicron or other variants). Currently, COVID-19 tests are designed and authorized to check broadly for the SARS-CoV-2 virus, not for specific variants.

The Omicron variant has a deletion in the spike (S) gene (Δ69-70). Some molecular tests with multiple genetic targets include a target covering the portion of the S gene where the deletion occurs. The presence of this mutation can result in an S-gene target failure (SGTF, also referred to as an S-gene drop out). The S-gene target will fail (return as negative) while other targets are expected to remain positive in the presence of this virus. SGTF can signal the need for sequencing to characterize the variant in a specimen.
SGTF has been observed in other variants and thus is not specific to the Omicron variant


15 posted on 12/26/2021 9:38:09 AM PST by Bob434
[ Post Reply | Private Reply | To 9 | View Replies]

To: SeekAndFind

Perhaps I was unclear. Her JAN 2021 infection and recovery should have given her acquired immunity for COVID alpha-delta. Assuming this new positive test is omicron ... draw your own conclusion.


16 posted on 12/26/2021 9:56:48 AM PST by MacNaughton
[ Post Reply | Private Reply | To 13 | View Replies]

To: DoodleBob; ransomnote

Ping.


17 posted on 12/26/2021 10:00:10 AM PST by upchuck (The longer I remain unjabbed with the clot-shot, the more evidence I see supporting my decision.)
[ Post Reply | Private Reply | To 1 | View Replies]

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.

Free Republic
Browse · Search
News/Activism
Topics · Post Article

FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson